lexiara

sec_3_3__para__9

COMMISSION NOTICE – Guidance on the interpretation and application of Directive 2005/29/EC of the European Parliament and of the Council concerning unfair business-to-consumer commercial practices in the internal market · European Union

Article 7 of Regulation (EU) 2017/745 of the European Parliament and of the Council (252) on medical devices and Article 7 of Regulation (EU) 2017/746 of the European Parliament and of the Council (253) on in vitro diagnostic medical devices have introduced at EU level a prohibition on claims in labelling, instructions for use or advertising that mislead the user or patient with regard to the device’s intended purpose, safety or performance, notably by:

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-09-25 · Text as adopted (Official Journal); later amendments are not incorporated in this text.